Oncobesity News Posts

Oprah Reveals Why She Went Back on GLP-1 Meds After Year-Long Break
Photo Illustration by The Daily Beast/Getty Oprah Winfrey, 71, revealed the reason she returned to taking GLP-1 drugs after taking a year-long break while voicing

SOTA On Bay Area House Party
[previously in series: 1, 2, 3, 4, 5, 6, 7, 8] Every city parties for its own reasons. New Yorkers party to flaunt their wealth.

Oprah Gets Open and Honest About Her Experience Taking a GLP-1 Weight Loss Drug
Oprah opened up about the unpleasant side effect she has experienced while taking this weight loss drug.

Eli Lilly working with Humana to dispense weight-loss drugs in employer-focused initiative
Humana’s CenterWell Pharmacy will distribute Eli Lilly obesity medications under a new program targeting employers, according to a Jan. 12 news release. The pharmacy will serve those

FDA Says to Drop Suicide Warning From GLP-1 Drug Labels
(MedPage Today) — The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following

FDA calls on GLP-1 drugmakers to remove suicide warnings – Axios
FDA calls on GLP-1 drugmakers to remove suicide warnings Axios US FDA requests removal of suicide warnings from weight-loss drugs CNN US FDA requests removal of suicide

FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
The FDA asked Novo Nordisk and Eli Lilly to remove warnings about suicidal ideation or behavior from the labels of their blockbuster GLP-1 weight loss

Giving up the booze
Americans are drinking less than ever—and a growing share are teetotalers. What’s behind the trend? What do the numbers show? That the U.S. is losing

Increased levels of Alzheimer’s-linked protein found in some with long COVID
A study of 227 individuals who experienced neurocognitive difficulties post COVID-19 infection—such as headaches, vertigo, balance dysregulation, changes in taste/smell, and brain fog—displayed a significant

New combination therapy developed for frequent form of lung cancer
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer.

Brain neurons process salience, valence and value separately to understand what is important—and what isn’t
The sound of a fire alarm tells us to get out quickly to not get hurt, while the sight of a gas station sign can

Healthcare Governance, Regulations, and Compliance – 2026 Health IT Predictions
As we wrap up another year and get ready for 2026 to begin, it is once again time for everyone’s favorite annual tradition of Health

GLP-1s, tariffs and health: Why food brands are reformulating
Food reformulation is a a way to adapt to challenges, such as commodity price rises, regulations or tariffs. It is also a way to embrace

Is Ozempic Really Making People Lose Their Hair?
Are GLP-1 drugs like Ozempic directly causing hair loss? A prolonged calorie deficit can disrupt our hair cycle and cause a temporary form of hair

The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Lam Research and Ampco-Pittsburgh
For Immediate Release Chicago, IL – January 13, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks

US FDA requests removal of suicide warnings from weight-loss drugs – CNN
US FDA requests removal of suicide warnings from weight-loss drugs CNN FDA calls on GLP-1 drugmakers to remove suicide warnings Axios FDA Wants Suicide Warning Removed From

How Weight Loss Pills Could Reshape The GLP-1 Landscape
Injectable GLP-1s for obesity have been revolutionary products of the pharmaceutical industry over the past few years. Now, for the first time, the weight loss

Trump Talks About Taking GLP-1s; New MiniMed System OK’d; Testosterone in Diet Recs
(MedPage Today) — President Trump said he’s never taken GLP-1 receptor agonists but said he “probably should.” (New York Times) People with diabetes and cancer
Hims GLP1
Simplify weight loss into something more manageable with Hims’s personalized care. Visit Uncrate for the full post.

FDA requests removal of suicide warnings from weight-loss drugs – CNBC
FDA requests removal of suicide warnings from weight-loss drugs CNBC US FDA requests removal of suicide warnings from weight-loss drugs CNN FDA calls on GLP-1 drugmakers to

Vanessa Williams Opens Up About Using GLP-1 During Menopause: ‘Science Is Amazing’
The 62-year-old opens up about embracing medical options like GLP-1 medication and hormone therapy to support her aging journey.

The Company Behind the 'Steroid Olympics' Wants To Make Enhanced Pro Athletes Mainstream—and Amateurs, Too
Illustration: Eddie Marshall | Midjourney Hello and welcome to another edition of Free Agent! It’s a great week to grate some cheese thanks to the

New human clinical data puts botanicals into the GLP-1 spotlight
California-based Gateway Health Alliances (GHA) has unveiled new human clinical data showing that two botanical extracts known for their metabolic health benefits boost the activity

The Company Behind the ‘Steroid Olympics’ Wants To Make Enhanced Pro Athletes Mainstream—and Amateurs, Too
Hello and welcome to another edition of Free Agent! It’s a great week to grate some cheese thanks to the new food pyramid. Today’s edition

FDA requests removal of suicide warnings from weight-loss drugs
The request follows a review by the FDA that found no evidence linking GLP-1 receptor agonists to an increased risk of suicidal thoughts or behavior.

Why 2026 is Already a NIGHTMARE for China | China Decode
In the wake of Trump’s invasion of Venezuela, how will China respond to the ongoing protests in Iran? In this episode of China Decode, Alice

New fleet of weight loss drugs are more effective than the current popular obesity medications at trial
One in eight Americans are taking a GLP-1 drug, a recent poll found

Ro Partners With Amgen to Study Barriers to Obesity Care, GLP-1 Access
Jan 13 (Reuters) – U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen to examine challenges…

Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?
Key Points Eli Lilly and Novo Nordisk make the world’s most popular weight loss drugs. These injectable products have generated double-digit growth, with revenue reaching

Ro与安进合作研究肥胖症治疗障碍及GLP-1药物获取问题
Ro partners with Amgen to study barriers to obesity care, GLP-1 access (www.reuters.com) 01-13

Day 1 @ JP Morgan
JP Morgan 2026: Obesity & GLP-1 Therapies Take Center StageWhat the Latest Deals and Data Mean for the Future of Metabolic MedicineThe J.P. Morgan Healthcare

Serena Williams on Taking a GLP-1: ‘I Feel Like I’m Back’
The G.O.A.T. says we shouldn’t be shamed about what helps us feel better in our bodies.

IMPACT X Nightline S04E04 1080p DSNP WEB-DL H264-RAWR
Season 4, Episode 04 – As more people take Ozempic, Mounjaro and other GLP-1 so-called “skinny shots,” a black market grows of fakes and counterfeits.

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications

FDA asks Lilly, Novo to remove suicide warning related to GLP-1 obesity drugs
Post Content
Oprah Winfrey opens up about weight journey: “I just want people to stop blaming themselves”
Oprah Winfrey is opening up about her personal weight journey. In her new book, “Enough: Your Health, Your Weight and What It’s Like To Be

Aon’s Latest GLP-1 Research Reveals Long-Term Employer Cost Savings and Significant Reductions in Cancer Risk for Women
CHICAGO, Jan. 13, 2026 /PRNewswire/ — Aon plc (NYSE: AON), a leading global professional services firm, today released updated findings from its multi-year study of

Parents weighing GLP-1 drugs for kids | Morning in America
Obesity now affects roughly 20% of U.S. children, according to the CDC, and families are searching for solutions that could include injectable weight loss drugs

Novo Nordisk sees pills capturing over third of GLP-1 market by 2030 | REUTERS
Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said, a larger percentage

GLP-1 Drugs Are Lowering Americans’ Grocery Bills
Cornell University When Americans begin taking appetite-suppressing drugs like Ozempic and Wegovy, the changes extend well beyond the bathroom scale. According to new research, the…